glp 1 compounding news US FDA clarifies policies on of GLP-1 medicines Ole Miss researchers study barriers

Considering that type 2 diabetes increases the risk of both primary open-angle glaucoma (POAG) and neovascular glaucoma, a group of researchers investigated the incidence of these diseases in patients taking GLP-1 receptor agonists

10.1016/j.ahj.2023.09.007 [DOI] [PubMed] [Google Scholar] 40

Ive never heard that before

Reduction of wrinkles and fine lines: Topical application of GHK-Cu at 1-3% significantly improves the depth and volume of wrinkles

Meanwhile, Lemon Bottle offers a gentler approach to fat reduction, which usually results in minimal downtime

Third, we did not include imaging modalities to confirm the NAFLD diagnosis (e.g